Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001185185-26-000269
Filing Date
2026-01-26
Accepted
2026-01-26 06:30:14
Documents
2
Period of Report
2026-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K anbio6k012526.htm 6-K 14134
2 EXHIBIT 10.1 anbioex10-1.htm EX-10.1 30548
  Complete submission text file 0001185185-26-000269.txt   45734
Mailing Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308
Business Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 4916096247281
Anbio Biotechnology (Filer) CIK: 0001982708 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42526 | Film No.: 26558374
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)